Status:
COMPLETED
A Study to Evaluate the Efficacy and Safety of AD-203
Lead Sponsor:
Addpharma Inc.
Conditions:
Acute Gastritis
Chronic Gastritis
Eligibility:
All Genders
20-75 years
Phase:
PHASE3
Brief Summary
This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compar...
Eligibility Criteria
Inclusion
- Age is over 20 years old, under 75 years old, men or women
- Patients diagnosed with acute or chronic gastritis by gastroscopy
Exclusion
- Patients who is impossible to receive gastroscopy
- Patients taking other investigational drugs or participating in other clinical studies in 3 months prior to screening visit
Key Trial Info
Start Date :
September 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 26 2020
Estimated Enrollment :
475 Patients enrolled
Trial Details
Trial ID
NCT04066530
Start Date
September 23 2019
End Date
February 26 2020
Last Update
December 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Guro Hospital
Seoul, South Korea